| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $110K | — | -87.3% |
| Cost of Revenue | $32K | — | -27.3% |
| R&D Expense | $15.8M | — | +17.1% |
| SG&A Expense | $6.4M | — | +1.8% |
| Operating Income | -$22.1M | — | -16.7% |
| Net Income | -$20.7M | — | -10.3% |
| EPS (Basic) | -$0.33 | — | +32.7% |
| EPS (Diluted) | -$0.33 | — | +32.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.4M | -18.2% | +54.6% |
| Short-term Investments | $66.0M | -8.1% | +109.4% |
| Accounts Receivable | $84K | -11.6% | -5.6% |
| Inventory | $277K | -10.6% | +105.2% |
| Current Assets | $96.2M | -10.8% | +85.4% |
| Total Assets | $100.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.2M | — | -33.4% |
| Capital Expenditures | $184K | — | +64.3% |
| Investing Cash Flow | $10.3M | — | -20.6% |
| Financing Cash Flow | $5.5M | — | +1967.2% |
| Free Cash Flow | -$22.4M | — | -33.6% |
| +70.5% |
| Current Liabilities | $13.7M | -18.2% | -11.6% |
| Long-term Debt | $15.0M | +0.0% | +0.0% |
| Total Liabilities | $49.7M | -3.5% | +17.8% |
| Stockholders' Equity | $41.2M | -23.1% | +144.4% |